M&A Deal Summary

Comac Medical Acquires ILife Consulting

On May 22, 2025, Comac Medical acquired life science company ILife Consulting

Acquisition Highlights
  • This is Comac Medical’s 1st transaction in the Life Science sector.
  • This is Comac Medical’s 1st transaction in France.

M&A Deal Summary

Date 2025-05-22
Target ILife Consulting
Sector Life Science
Buyer(s) Comac Medical
Deal Type Add-on Acquisition

Target

ILife Consulting

Paris, France
ILife Consulting is a CRO specialized in early-phase oncology and biotech development, specializing in oncology, rare diseases, novel therapeutic modalities, and complex regulatory environments. ILIFE accelerates timelines, optimizes data quality, and helps its clients make confident, value-driven decisions. ILife Consulting was founded in 2013 and is based in Paris, France.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Comac Medical

Sofia, Bulgaria

Category Company
Founded 1997
Sector Life Science
DESCRIPTION

Comac Medical is a full-service clinical research organization (CRO) in South-Eastern Europe, present in more than 30 countries, providing a comprehensive range of early to late-phase drug development services to the global pharmaceutical and biotech industries across a variety of therapeutic areas with a differentiated expertise and track record for indications within oncology, dermatology, gastroenterology, and respiratory diseases. The Company has a global customer base consisting of emerging biotech and established pharmaceutical companies, offering full outsourced clinical trial support across the entire clinical development timeline. Comac Medical was formed in 1997 and is based in Sofia, Bulgaria.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2025 M&A 1 of 1